Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Sherrington Robin currently holds 65,000 shares of Xenon Pharmaceuticals Inc. (XENE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sherrington Robin has been a net seller of XENE stock. They have purchased $0 and sold $3.6M worth of shares.
Sherrington Robin's most recent insider trade was on Mar 11, 2024, when they sold 65,000 shares at $0.00 per share.
Sherrington Robin serves as Executive at Xenon Pharmaceuticals Inc. (XENE). They have executed 45 insider transactions totaling $3.6M over their tenure at the company.
Sherrington Robin holds the position of Executive at Xenon Pharmaceuticals Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Sherrington Robin has shown a selling trading pattern, with $0 in total purchases and $3.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Sherrington Robin was on Sep 1, 2022, when they sold $1.3M worth of XENE shares. This transaction involved 35,103 shares at $38.03 per share.
Sherrington Robin currently owns 65,000 shares of Xenon Pharmaceuticals Inc. (XENE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Sherrington Robin's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Sherrington Robin has 45 Form 4 filings on record as an insider at Xenon Pharmaceuticals Inc..
Set alerts for Sherrington Robin and 40,000+ other insiders.